Manejo desde atención primaria de la infección por la viruela del mono (MPOX) en humanos

Izquierdo, Javier Arranz; Molero García, José María; Gutiérrez Pérez, María Isabel.
Aten. prim. (Barc., Ed. impr.) ; 55(10): 102680, Oct. 2023. graf, tab, ilus
Artículo en Español | IBECS (España) | ID: ibc-226020

Documentos relacionados

  1. Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.
  2. Human Monkeypox Virus and Host Immunity: New Challenges in Diagnostics and Treatment Strategies.
  3. Underdetected dispersal and extensive local transmission drove the 2022 mpox epidemic.
  4. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease.
  5. Can a smallpox drug treat monkeypox? Here's what scientists know.
  6. Mpox infection protects against re-challenge in rhesus macaques.
  7. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
  8. Monkeypox treatment: Current evidence and future perspectives.
  9. Drug Sensitivity of Currently Circulating Mpox Viruses.
  10. Monkeypox Virus Neutralizing Antibodies at Six Months from Mpox Infection: Virologic Factors Associated with Poor Immunologic Response.